Nadiminti, Kalyan V. G.
Sahasrabudhe, Kieran D.
Liu, Hongtao
Article History
Received: 30 June 2024
Accepted: 5 November 2024
First Online: 18 November 2024
Declarations
:
: Not applicable.
: KN is a site PI for the KOMET-007 study, received research support from Abbvie Inc, served at the advisory board meeting for Morphosys. KS reports no competing interests for this review. HL reports no competing interests for this review; HL served at the Advisory Board meeting for Servier and Rigel and received a consulting fee from AbbVie in the past 24 months